Abstract
Introduction
Lessons from cell therapy
Cardiac tissue engineering
In vivo CTE applications
In vitro CTE applications
Conclusions
Tissue engineering is an increasingly expanding area of research in the cardiovascular field that involves engineering, chemistry, biology and medicine. Cardiac tissue engineering (CTE) aims to regenerate myocardial damage by combining cells, matrix, biological active molecules and physiological stimuli. The rationale behind CTE applications is that in order to regenerate the ventricular wall after a myocardial infarction it is necessary to combine procedures that regenerate both cardiomyocytes and the extracellular matrix. The application of (stem) cells together with a matrix could represent an environment protected from the inflammatory and pro-apoptotic signals, a stemness/survival reservoir slowly releasing cells and factors promoting tissue regeneration and angiogenesis. This review will focus on the applications and advantages that CTE application could offer compared to conventional cell therapy.
Original language | English |
---|---|
Pages (from-to) | 1071-1077 |
Number of pages | 7 |
Journal | Journal of Cellular and Molecular Medicine |
Volume | 14 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2010 |
Keywords
- cell therapy
- cardiac regeneration
- cardiac tissue engineering
- cardiac progenitor cells
- cardiospheres
- LEFT-VENTRICULAR FUNCTION
- PROGENITOR CELLS
- PEPTIDE NANOFIBERS
- CARDIAC REPAIR
- PDGF-BB
- IN-VIVO
- INFARCTION
- HEART
- DELIVERY
- SCAFFOLD